First-Line Treatment with Tiotropium/Olodaterol Improves Physical Activity in Patients with Treatment-Naïve Chronic Obstructive Pulmonary Disease

First-Line Treatment with Tiotropium/Olodaterol Improves Physical Activity in Patients with Treatment-Naïve Chronic Obstructive Pulmonary Disease

Koichiro Takahashi,1 Masaru Uchida,2 Go Kato,3 Ayako Takamori,4 Takashi Kinoshita,5 Makoto Yoshida,6 Ryo Tajiri,4 Keisuke Kojima,7 Hiroshi Inoue,8 Hiromi Kobayashi,9 Hironori Sadamatsu,1 Hiroki Tashiro,1 Masahide Tanaka,1 Shinichiro Hayashi,10 Atsushi Kawaguchi,4,11 Shinya Kimura,1 Naoko Sueoka-Arag...

Full description

Bibliographic Details
Main Authors: Takahashi K, Uchida M, Kato G, Takamori A, Kinoshita T, Yoshida M, Tajiri R, Kojima K, Inoue H, Kobayashi H, Sadamatsu H, Tashiro H, Tanaka M, Hayashi S, Kawaguchi A, Kimura S, Sueoka-Aragane N, Kawayama T
Format: Article
Language:English
Published: Dove Medical Press 2020-09-01
Series:International Journal of COPD
Subjects:
chronic obstructive pulmonary disease
physical activity
long-acting muscarinic antagonist
long-acting beta 2 agonist
Online Access:https://www.dovepress.com/first-line-treatment-with-tiotropiumolodaterol-improves-physical-activ-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/first-line-treatment-with-tiotropiumolodaterol-improves-physical-activ-peer-reviewed-article-COPD

Similar Items